36 research outputs found

    The pathophysiological role of dendritic cell subsets in psoriasis

    Get PDF
    Psoriasis is a chronic inflammatory disorder characterized by an erythematous scaly plaque of the skin and is occasionally accompanied by systemic complications. In the psoriatic lesions, an increased number of cytokine-producing dendritic cells and activated T cells are observed, which indicate that psoriasis is a prototype of an immune-mediated dermatosis. During the last decade, emerging studies demonstrate novel roles for the dendritic cell subsets in the process of disease initiation and maintenance of psoriasis. In addition, recently discovered anti-psoriatic therapies, which specifically target inflammatory cytokines produced by lesional dendritic cells, bring much better clinical improvement compared to conventional treatments. These new therapies implicate the crucial importance of dendritic cells in psoriasis pathogenesis. This review will summarize and discuss the dendritic cell subsets of the human skin and their pathophysiological involvement in psoriasis based on mouse- and patient-oriented studies.ope

    Mean platelet volume is elevated in patients with psoriasis vulgaris

    Get PDF
    PURPOSE: This retrospective study was done to investigate the mean platelet volume (MPV) level in patients with psoriasis vulgaris and its relationship with disease severity. MATERIALS AND METHODS: We undertook a cross-sectional study on 176 patients and 101 healthy controls to examine the association between MPV and psoriasis. Various clinical and laboratory parameters were analyzed and compared. RESULTS: Platelet distribution width and MPV were significantly higher in patients with psoriasis than controls. In addition, there was positive correlation between Psoriasis Area Severity Index (PASI) and MPV. When psoriasis patients were grouped into mild psoriasis (PASI<10) and moderate to severe psoriasis (PASIโ‰ฅ10), the MPV of the latter group was significantly elevated. Nevertheless, patients with higher MPV level (MPVโ‰ฅ10.4 fL) did not show higher PASI than lower MPV level (MPV<10.4 fL). MPV levels significantly decreased after improvements of psoriasis with various treatments. The variations of MPV and PASI also showed significant correlation. CONCLUSION: We have shown that MPV is increased in psoriasis patients and correlates with disease severity. Therefore, MPV levels may be considered as a marker of disease severity of psoriasis.ope

    ์‹ธ์ดํ† ์นด์ธ์— ์˜ํ•œ ์„ฑ์ˆ™ ๊ธฐ๊ฐ„

    No full text
    Dept. of Medicine/์„์‚ฌ[ํ•œ๊ธ€] ์ˆ˜์ง€์ƒ์„ธํฌ๋Š” ๋ฉด์—ญ ๋ฐ˜์‘์˜ ์œ ๋„ ๋ฐ ์กฐ์ ˆ์— ์ค‘์š”ํ•œ ์—ญํ• ์„ ํ•œ๋‹ค. ๋ฏธ์„ฑ์ˆ™ ์ˆ˜์ง€์ƒ์„ธํฌ๋Š” MHC class II ๊ฒฝ๋กœ๋ฅผ ํ†ตํ•œ ๋‹จ๋ฐฑ์งˆ ํ•ญ์› ์ „๋‹ฌ ๊ธฐ๋Šฅ์„ ๋งค์šฐ ํšจ์œจ์ ์œผ๋กœ ์ˆ˜ํ–‰ํ•œ๋‹ค. ์„ฑ์ˆ™ ์ˆ˜์ง€์ƒ์„ธํฌ๋Š” T ์„ธํฌ์˜ ์„ฑ์žฅ ๋ฐ ๋ถ„ํ™”๋ฅผ ์œ ๋ฐœํ•˜๋Š” ์—ญํ• ์„ ํ•œ๋‹ค. ์ธํ„ฐ๋ฃจํ‚จ-12๋Š” ์ˆ˜์ง€์ƒ์„ธํฌ์™€ T ์„ธํฌ์˜ ์ƒํ˜ธ ์ž‘์šฉ์—์„œ ๋งค์šฐ ์ค‘์š”ํ•œ ์—ญํ• ์„ ํ•˜๋Š” ์ธ์ž ์ค‘ ํ•˜๋‚˜์ด๋‹ค. ์ธํ„ฐ๋ฃจํ‚จ-12๋Š” T ์„ธํฌ ๋ฐ NK ์„ธํฌ์— ์ž‘์šฉํ•˜์—ฌ ์„ธํฌ์˜ ์„ฑ์žฅ๊ณผ ๋…์„ฑ์„ ์œ ๋ฐœ ๋ฐ ์ด‰์ง„ํ•˜๊ณ , IFN-ฮณ์˜ ์ƒ์„ฑ์„ ์ฆ๊ฐ€์‹œํ‚จ๋‹ค. ์ธํ„ฐ๋ฃจํ‚จ-12๋Š” Th1 ์„ธํฌ๋ฅผ ์œ ๋ฐœํ•˜๋Š”๋ฐ ์žˆ์–ด์„œ ๊ฐ€์žฅ ์ค‘์š”ํ•œ ์‹ธ์ดํ† ์นด์ธ์ด๋‹ค. ํ˜„์žฌ ์ˆ˜์ง€์ƒ์„ธํฌ๋ฅผ ์ด์šฉํ•œ ์—ฐ๊ตฌ๋Š” ๋Œ€๋ถ€๋ถ„ CD34 ์–‘์„ฑ ๊ธฐ์›์„ธํฌ๋‚˜ ํ˜ˆ์•ก์—์„œ ์ถ”์ถœํ•œ ๋‹จํ•ต๊ตฌ๋ฅผ ์ˆ˜์ง€์ƒ์„ธํฌ์™€ ์œ ์‚ฌํ•œ ์„ธํฌ๋กœ ์œ ๋„ํ•˜๋Š” ๊ธฐ์ˆ ์„ ๊ธฐ๋ฐ˜์œผ๋กœ ์ด๋ฃจ์–ด์ง„๋‹ค.์ฅ๋ฅผ ์ด์šฉํ•œ ์ €์ž๋“ค์˜ ์‹คํ—˜์—์„œ ์ˆ˜์ง€์ƒ์„ธํฌ์˜ ํ‘œ๋ฉดํ•ญ์› ๋ฐœํ˜„ ์ •๋„๊ฐ€ ์•„๋‹Œ ์ ์ ˆํ•œ ์ธํ„ฐ๋ฃจํ‚จ-12์˜ ๋ถ„๋น„๊ฐ€ ์ˆ˜์ง€์ƒ์„ธํฌ ๋ฉด์—ญ์น˜๋ฃŒ์— ์žˆ์–ด์„œ ๊ฐ€์žฅ ์ ํ•ฉํ•œ ๊ธฐ์ค€์ด ๋œ๋‹ค๋Š” ๊ฒƒ์„ ๋ฐํ˜€๋ƒˆ๋‹ค. ๋”ฐ๋ผ์„œ ์ด๋ฒˆ ์—ฐ๊ตฌ์—์„œ ์ €์ž๋“ค์€ ์ธ๊ฐ„ ๋‹จํ•ต๊ตฌ ์œ ๋ž˜ ์ˆ˜์ง€์ƒ์„ธํฌ์˜ ํ‘œ๋ฉดํ•ญ์› ๋ฐœํ˜„๊ณผ ์„ธํฌ๋‚ด ์ธํ„ฐ๋ฃจํ‚จ-12 ๋ฐœํ˜„, ์ธํ„ฐ๋ฃจํ‚จ-12 ๋ถ„๋น„ ๋“ฑ์ด ์ผ๊ด€๋œ ์–‘์ƒ์„ ๋‚˜ํƒ€๋‚ด์ง€ ์—ฌ๋ถ€๋ฅผ ์•Œ์•„๋ณด๊ณ ์ž ํ•˜์˜€๋‹ค.์—ฐ๊ตฌ ๊ฒฐ๊ณผ, ํ‘œ๋ฉดํ•ญ์› ๋ฐœํ˜„์ƒ์œผ๋กœ ์ˆ˜์ง€์ƒ์„ธํฌ์˜ ์ตœ๊ณ  ์„ฑ์ˆ™ ์‹œ๊ธฐ๋Š” 7์ผ์งธ์ด์—ˆ๊ณ , ๋งˆ์ฐฌ๊ฐ€์ง€๋กœ ์„ธํฌ๋‚ด ์ธํ„ฐ๋ฃจํ‚จ-12 ํ‘œํ˜„ ์ •๋„๋„ 7์ผ์งธ ์ตœ๊ณ ๋กœ ๋†’๊ฒŒ ๋‚˜ํƒ€๋‚ฌ๋‹ค. ๋ณธ ์—ฐ๊ตฌ์—์„œ ์ธํ„ฐ๋ฃจํ‚จ-12์˜ ๋ถ„๋น„๋Ÿ‰์€ ๊ทธ ์–‘์ด ๋„ˆ๋ฌด ์ ์–ด์„œ ์˜๋ฏธ๋ฅผ ๋ถ€์—ฌํ•˜๊ธฐ ํž˜๋“ค๊ธฐ ๋•Œ๋ฌธ์— ์ž๋ฃŒ ๋ถ„์„์„ ํ•  ์ˆ˜ ์—†์—ˆ๋‹ค. ๊ฒฐ๋ก ์ ์œผ๋กœ ๋น„๋ก ์ธํ„ฐ๋ฃจํ‚จ-12์˜ ๋ถ„๋น„๋Ÿ‰์€ ์ ์—ˆ์ง€๋งŒ, ํ‘œ๋ฉดํ•ญ์› ๋ฐœํ˜„๊ณผ ์„ธํฌ๋‚ด ์ธํ„ฐ๋ฃจํ‚จ-12 ๋ฐœํ˜„์€ ๋ชจ๋‘ 7์ผ์งธ ์ œ์ผ ๋†’๊ฒŒ ๋‚˜ํƒ€๋‚ฌ๋‹ค. ๋”ฐ๋ผ์„œ ์ˆ˜์ง€์ƒ์„ธํฌ ๋ฉด์—ญ์น˜๋ฃŒ์— ์žˆ์–ด์„œ 7์ผ์งธ์˜ ์ˆ˜์ง€์ƒ์„ธํฌ๋ฅผ ์ด์šฉํ•˜๋Š” ๊ฒƒ์ด ์ ์ ˆํ•œ ๋ฐฉ๋ฒ• ์ค‘ ํ•˜๋‚˜๋ผ๊ณ  ์ƒ๊ฐ๋œ๋‹ค. [์˜๋ฌธ] Dendritic cells (DCs) play an important role in the generation and regulation of immune responses. Immature DCs are very effective in processing native protein antigens for the MHC class II restricted pathway. Mature DCs are specialized to stimulate resting T cells to grow and differentiate. Interleukin-12 (IL-12) is a crucial factor in the moment of dendritic cell/T cell interaction in the lymphoid organ. IL-12 acts on T cells and NK cells by inducing proliferation, enhancing cytotoxicity, and promoting IFN-ฮณ production. It is most important cytokine for induction of Th1 cells. Currently most studies on DCs rely on the in vitro development of DC-like cells from CD34+ progenitor cells of blood monocytes. In our unpublished previous report, proper production of IL-12, not fully expressed molecules representing mature DCs, was optimal criteria of DCs for DCs immunotherapy in murine system. Therefore the purpose of this study is to investigate whether there is discordance among the expressions of surface molecules, intracytoplasmic IL-12 expressions and IL-12 secretion in human monocytes-derived DCs (MoDCs). In this study the optimal day, which DCs become phenotypically most mature, was day 7 and intracytoplasmic IL-12p40 expressions were also highest on day 7. The amounts of IL-12 secreted by mature DCs in this study were so small that they were excluded in data analysis. In conclusion even though the amounts of IL-12 secretions were too small, the pattern of surface molecules expressions and intracytoplasmic IL-12 expressions coincided and both were highest on day 7 in human monocytes-derived DCs. So we think sufficiently matured day 7 DCs are proper candidate to be used in DC immunotherapies.ope
    corecore